Politicians and scientists alike often discuss personalized medicine as the future of heath care. Personalized medicine would mean that researchers could use a patient’s specific genetic make-up to develop a specific treatment. In an innovative approach, researchers work to develop miniature pigs with patient-specific genetic mutations. Award-winning science writer Ed Yong explains how researchers aim to utilize the gene editing technology known as CRISPR to help treat neurofibromatosis. getAbstract recommends this article to those interested in cutting-edge, gene editing technology.
In this summary, you will learn
- What kind of disease neurofibromatosis type 1 is,
- What the modern, gene editing technique “CRISPR” is capable of,
- How miniature pigs can help scientists learn more about an individual’s disease progression.
About the Author
Ed Yong is an award-winning science writer at The Atlantic and author of several books.